Hospira Inc. et al v. Eurohealth International Sarl et al.

(#112) NOTICE OF SERVICE of (i) the Rebuttal Expert Report of Michael A.E. Ramsay, M.D. on Validity of U.S. Patent No. 6,716,867; and (ii) the Second Expert Report of Mohan Rao, Ph.D. filed by Hospira Inc., Orion Corporation.(Hickie, Sarah) (Entered: 02/17/2016)

(#111) NOTICE OF SERVICE of 1. Rebuttal Expert Report of Ivan T. Hofmann, CPA/CFF, CLP; 2. Rebuttal Expert Report of Stephen Small, M.D. Regarding Non-Infringement; and 3. Rebuttal Expert Report of Gourang Patel, B.S. Chem, Pharm.D., MSC., BCCCP, BCPS filed by Eurohealth International Sarl, West-Ward Pharmaceuticals Corp..(Keller, Karen) (Entered: 02/17/2016)

(#110) STIPULATION (and proposed order) to extend deadlines to exchange Rebuttal Expert Reports to February 16, 2016; to exchange Reply Expert Reports to March 8, 2016; and to Complete Expert Discovery by March 30, 2016 re (96 in 1:14-cv-01008-GMS, 102 in 1:14-cv-00487-GMS) Stipulation, (31 in 1:14-cv-00487-GMS, 25 in 1:14-cv-01008-GMS) Proposed Order by Eurohealth International Sarl, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals Corp.. (Keller, Karen) (Entered: 02/11/2016)

(#109) ORDER Setting Mediation Conferences: A Mediation Conference is set for 5/26/2016 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/1/16. (cak) (Entered: 02/01/2016)

(#108) ORAL ORDER: Teleconferences with Judge Thynge have been scheduled as follows: 2/16/16 at 10:00 AM Eastern Time (counsel were initially told the teleconference would be at 9:30. Due to a scheduling conflict it had to be moved to 10:00) to be initiated by defense counsel. 3/7/16 at 8:30 AM Eastern Time to be initiated by plaintiff's counsel. Ordered by Judge Mary Pat Thynge on 1/27/16. Associated Cases: 1:14-cv-00487-GMS, 1:14-cv-01008-GMS(cak) (Entered: 01/27/2016)

(#107) ORAL ORDER: A teleconference has been scheduled for 1/27/16 at 11:30 AM EASTERN TIME with Judge Thynge. Counsel for Hospira shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 1/21/16. (cak) (Entered: 01/21/2016)

(#106) NOTICE OF SERVICE of 1. Expert Report of Jesse B. Hall, M.D. and 2. Defendants Eurohealth International Sarl and West-Ward Pharmaceutical Corp.'s Second Supplemental Preliminary Invalidity Contentions filed by Eurohealth International Sarl, West-Ward Pharmaceuticals Corp..(Keller, Karen) (Entered: 01/18/2016)

(#105) NOTICE OF SERVICE of (i) the Opening Expert Report of Charles Medico, Pharm.D., BCPS; (ii) the Opening Expert Report of Bruce Friedman, M.D., on Infringement of U.S. Patent No. 6,716,867; and (iii) the Opening Expert Report of Mohan Rao, Ph.D. filed by Hospira Inc., Orion Corporation.(Hickie, Sarah) (Entered: 01/15/2016)

(#104) NOTICE OF SERVICE of Plaintiffs' Amended Supplemental Infringement Contentions re 65 Notice of Service filed by Hospira Inc., Orion Corporation.(Hickie, Sarah) (Entered: 01/13/2016)

(#103) SO ORDERED - re (96 in 1:14-cv-01008-GMS, 102 in 1:14-cv-00487-GMS) Stipulation and Proposed Order to Amend Scheduling Order Scheduling Order Deadlines: ( Fact Discovery completed by 1/7/2016., Opening Expert Reports due by 1/15/2016., Rebuttal Expert Reports due by 2/12/2016., Reply Expert Reports due by 3/4/2016., Expert Discovery due by 3/29/2016., Proposed Pretrial Order due by 5/2/2016.). Signed by Judge Gregory M. Sleet on 12/14/2015. Associated Cases: 1:14-cv-00487-GMS, 1:14-cv-01008-GMS(mdb) (Entered: 12/15/2015)

(#10) ANSWER to 8 Answer to Complaint, Counterclaim -- Plaintiffs' Answer to Ben Venue's Counterclaims -- by Hospira Inc., Orion Corporation.(Matterer, Mary) (Entered: 08/04/2014)

(#9) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim Corporation for Ben Venue Laboratories Inc. filed by Ben Venue Laboratories Inc.. (Fry, David) (Entered: 07/11/2014)

(#8) ANSWER to 1 Complaint, , COUNTERCLAIM against Hospira Inc., Orion Corporation by Ben Venue Laboratories Inc..(Fry, David) (Entered: 07/11/2014)

(#7) SUMMONS Returned Executed by Orion Corporation, Hospira Inc.. Ben Venue Laboratories Inc. served on 6/26/2014, answer due 7/17/2014. (Matterer, Mary) (Entered: 06/26/2014)

(#6) MOTION for Pro Hac Vice Appearance of Attorney Yusuf Esat, Attorney Sara Tonnies Horton, and Attorney Bradford P. Lyerla - filed by Hospira Inc., Orion Corporation. (Matterer, Mary) (Entered: 04/28/2014)

(#5) Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Price T. Rowe Associates Inc. for Hospira Inc. filed by Hospira Inc., Orion Corporation. (dmp, ) (Entered: 04/21/2014)

(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,716,867;. (dmp, ) (Entered: 04/21/2014)

(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/06/2013. Date of Expiration of Patent: 03/31/2019. Thirty Month Stay Deadline: None (dmp, ) (Entered: 04/21/2014)

(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 04/21/2014)

(#1) COMPLAINT filed against Ben Venue Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1500688.) - filed by Orion Corporation, Hospira Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 04/21/2014)